Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care
OPEN BMJ (Clinical research ed.) | 6 Jul 2018
Y Vinogradova, C Coupland, T Hill and J Hippisley-Cox
To investigate the associations between direct oral anticoagulants (DOACs) and risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality compared with warfarin.
* Data courtesy of Altmetric.com